Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Int J Infect Dis ; 117: 251-257, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34029706

ABSTRACT

OBJECTIVES: To describe the investigation, follow-up, management, and outcomes in a cohort of chronic kidney disease (CKD) and kidney transplant recipients (KTR) exposed to a case of pulmonary tuberculosis (TB). METHODS: Contacts were investigated following a concentric circles approach and followed-up according to their level of priority. In those with evidence of latent TB infection, treatment decision was based on the level of exposure, individual vulnerability, as well as the results of an interferon-gamma release assay. RESULTS: A total of 130 patients with CKD and 180 KTR were identified as contacts and followed-up over a 2-year period. Few vulnerable high-priority contacts received anti-TB treatment, including the two (100%) highly exposed patients in circle 1, 11/78 (14.1%) CKD patients and 4/142 (2.8%) KTR in circle 2, and 10/52 (19.2%) CKD patients and 2/36 (5.6%) KTR in circle 3; all had a positive interferon-gamma release assay result. No incident cases of TB disease occurred. CONCLUSIONS: These findings suggest that latent TB treatment, as recommended in European guidelines, might be reasonably avoided in vulnerable high-priority contacts of circle 2, with a negative interferon-gamma release assay and in countries with low prevalence of TB.


Subject(s)
Kidney Transplantation , Latent Tuberculosis , Nephrology , Tuberculosis, Pulmonary , Humans , Interferon-gamma Release Tests , Kidney Transplantation/adverse effects , Latent Tuberculosis/diagnosis , Latent Tuberculosis/drug therapy , Latent Tuberculosis/epidemiology , Tuberculin Test/methods , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/epidemiology
2.
Article in English | MEDLINE | ID: mdl-29229635

ABSTRACT

We report evidence, confirmed by the lack of travel activity outside of France and genetic diversity analysis using polymorphic microsatellite markers, that Plasmodium falciparum malaria infection effectively treated with an artemisinin-based combination can remain dormant and relapse during pregnancy at least 2 years after treatment.


Subject(s)
Antimalarials/therapeutic use , Malaria, Falciparum/drug therapy , Malaria, Falciparum/microbiology , Plasmodium falciparum/drug effects , Adult , Artemisinins/therapeutic use , Female , France , Genetic Variation/genetics , Humans , Plasmodium falciparum/genetics , Pregnancy , Recurrence , Travel
4.
Int J Dermatol ; 57(2): 227-230, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29090455

ABSTRACT

BACKGROUND: Furuncular myiasis is likely to be seen by Western dermatologists because of the increasing number of international travelers but remains unfamiliar to most of them, who tend to refer these patients to hospitals. Different treatments have been proposed, but many of them are not achievable in outpatient consultation. METHODS: We reported three typical cases of furuncular myiasis, according to each species involved, and proposed diagnostic and therapeutic guidelines for dermatologists in outpatient consultation. RESULTS: One patient, complaining of an inflammatory nodule of the leg with a central punctum, was diagnosed with Dermatobia hominis infection, after a forest walk in French Guiana. One woman returned from Senegal with a nodule of the left buttock. She had been infected by a Cordylobia anthropophaga larva after drying her underwear under a mango tree. One woman living in Cameroon presented with scalp nodules, pain, fatigue, and facial edema. She had been infected by more than 40 larvae of Cordylobia rodhaini after drying her sheets under a mango tree. Manual extraction ensured complete healing in the three patients. We used neither doppler ultrasound nor occlusive dressing. Diagnosis was immediately made thanks to the typical clinical stories. CONCLUSIONS: The diagnosis of furuncular myiasis requires only clinical skills and basic knowledge of life cycles. The treatment varies slightly depending on the species involved but is achievable in outpatient consultation and does not require occlusive dressing.


Subject(s)
Myiasis/diagnosis , Myiasis/therapy , Adult , Animals , Dermatology/methods , Diptera , Female , Humans , Male , Middle Aged , Myiasis/parasitology , Practice Guidelines as Topic , Travel-Related Illness
5.
PLoS One ; 12(7): e0181995, 2017.
Article in English | MEDLINE | ID: mdl-28759620

ABSTRACT

BACKGROUND: In Côte d'Ivoire, a TB prison program has been developed since 1999. This program includes offering TB screening to prisoners who show up with TB symptoms at the infirmary. Our objective was to estimate the prevalence of pulmonary TB among inmates at the Correctional and Detention Facility of Abidjan, the largest prison of Côte d'Ivoire, 16 years after this TB program was implemented. METHODS: Between March and September 2015, inmates, were screened for pulmonary TB using systematic direct smear microscopy, culture and chest X-ray. All participants were also proposed HIV testing. TB was defined as either confirmed (positive culture), probable (positive microscopy and/or chest X-ray findings suggestive of TB) or possible (signs or symptoms suggestive of TB, no X-Ray or microbiological evidence). Factors associated with confirmed tuberculosis were analysed using multivariable logistic regression. RESULTS: Among the 943 inmates screened, 88 (9.3%) met the TB case definition, including 19 (2.0%) with confirmed TB, 40 (4.2%) with probable TB and 29 (3.1%) with possible TB. Of the 19 isolated TB strains, 10 (53%) were TB drug resistant, including 7 (37%) with multi-resistance. Of the 10 patients with TB resistant strain, only one had a past history of TB treatment. HIV prevalence was 3.1% overall, and 9.6%among TB cases. Factors associated with confirmed TB were age ≥30 years (Odds Ratio 3.8; 95% CI 1.1-13.3), prolonged cough (Odds Ratio 3.6; 95% CI 1.3-9.5) and fever (Odds Ratio 2.7; 95% CI 1.0-7.5). CONCLUSION: In the country largest prison, pulmonary TB is still 10 (confirmed) to 44 times (confirmed, probable or possible) as frequent as in the Côte d'Ivoire general population, despite a long-time running symptom-based program of TB detection. Decreasing TB prevalence and limiting the risk of MDR may require the implementation of annual in-cell TB screening campaigns that systematically target all prison inmates.


Subject(s)
Prisoners/statistics & numerical data , Prisons/statistics & numerical data , Tuberculosis, Pulmonary/epidemiology , Adult , Cote d'Ivoire , Female , Humans , Male , Prevalence
8.
Malar J ; 13: 398, 2014 Oct 11.
Article in English | MEDLINE | ID: mdl-25306236

ABSTRACT

BACKGROUND: Parenteral artesunate is recommended as first-line therapy for severe and complicated malaria. Although its efficacy has been proven, long-term safety profile is still under evaluation. Several cases of delayed haemolytic anaemia occurred after initial clinical improvement and resolution of parasitaemia in non-immune travellers and children living in endemic areas. Reports have generated concern that this phenomenon might be related to the treatment itself, either by direct toxicity or immune-related mechanism. This is a report of the first case of autoimmune haemolytic anaemia following treatment of severe malaria initially managed with parenteral artesunate with strong indication for drug-immune related mechanism. CASE: A 17-year old Ivoirian female travelling in France presented with fever, headache and abdominal pain seven days after her arrival. Physical examination was indicative of septic shock while blood analysis showed normal haemoglobin level, but profound thrombocytopaenia and hyperlactataemia. Blood smear analysis showed Plasmodium falciparum infection with a parasitaemia of 0.8%. Severe malaria was diagnosed according to the WHO criteria. The patient was initially managed with artemether/lumefantrine combination and then parenteral artesunate for 48 hours. Empiric antibiotic course was also initiated with ceftriaxone, metronidazole, gentamycin, and then piperacillin and ciprofloxacin. At day 14, haemoglobin dropped to 4.6 g/dL with biologic features indicative of haemolysis (LDH 658 U/L, haptoglobin<0.15 g/L). At that time, parasitaemia was negative and other infections or hereditary disorders were excluded, while Coombs' direct antiglobulin test was positive for IgG and C3d. Antinuclear antibodies were absent. Further investigations evidenced drug-induced antibodies related to artesunate. It was concluded a drug-mediated autoimmune haemolytic anaemia. A corticosteroids regimen was initiated at 1 mg/kg/day. Outcome was favourable and corticosteroids were progressively tapered during two months. At present the patient's condition remains stable without recurrence of haemolytic anaemia. CONCLUSION: This is the first case of delayed haemolytic anaemia related to artesunate with a strong indication for drug-immune related mechanism. Further research is warranted to better characterize this plausible cause of post-treatment haemolysis following parenteral artesunate administration in severe malaria patients.


Subject(s)
Anemia, Hemolytic, Autoimmune/chemically induced , Antimalarials/adverse effects , Artemisinins/adverse effects , Malaria, Falciparum/drug therapy , Adolescent , Antimalarials/administration & dosage , Antimalarials/therapeutic use , Artemisinins/administration & dosage , Artemisinins/therapeutic use , Artesunate , Cote d'Ivoire , Female , France , Humans
10.
Intern Med ; 53(8): 899-902, 2014.
Article in English | MEDLINE | ID: mdl-24739615

ABSTRACT

The dengue virus is responsible for a wide range of symptoms that can be classified into two distinct syndromes: classical dengue fever and severe dengue fever. Among the complicating forms, hemophagocytic syndrome (HPS) has been previously reported in case series of patients with secondary dengue fever outside of endemic settings. Of note, the occurrence of HPS has not yet been included among the criteria for defining severe dengue fever. We herein present three patients with HPS related to confirmed primary dengue virus infection. Clinicians should therefore consider hemophagocytosis as a complication during severe dengue infection in naïve patients.


Subject(s)
Dengue/epidemiology , Lymphohistiocytosis, Hemophagocytic/epidemiology , Adult , Female , France , Humans , Male , Syndrome
11.
Curr HIV Res ; 8(6): 461-6, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20636276

ABSTRACT

BACKGROUND: Vaccination of asymptomatic human immunodeficiency virus (HIV)-infected patients with a CD4 cell count ≥ 200/mm³ is strongly suggested prior to travel to a region where yellow fever (YF) is endemic. However, few data describing YF vaccination in such patients are available. METHODS: In this retrospective observational study of 23 HIV-infected patients, YF antibody titers, CD4 cell counts, and viral loads were measured before and after vaccination. Serologies were performed retrospectively on samples that had been stored as part of routine hospital procedures. RESULTS: Ninety-three percent of patients (13/14) with no baseline immunity, seroconverted after vaccination. Immunogenicity appeared slowly; only 2 of the 5 patients tested within 5 weeks of vaccination had seroconverted. A booster effect was noted in 3 of the 9 patients with baseline immunogenicity. Finally, due to unawareness of his HIV status, one patient was vaccinated and was found later to have a CD4 cell count < 200/mm³.The YF vaccine was well tolerated and no serious adverse events were reported. The impact of vaccination on immunologic and viral parameters was variable. Both decreases (n = 7) and increases (n = 5) in CD4 cell counts were recorded. Viral loads became undetectable in 2 patients and doubled or became positive in 3 patients. CONCLUSIONS: Yellow fever vaccination was safe and effective in a large majority of this cohort of stable, HIV-infected patients.


Subject(s)
HIV Infections/immunology , HIV/immunology , Yellow Fever Vaccine/adverse effects , Yellow Fever/immunology , Yellow Fever/prevention & control , Adolescent , Adult , Antibodies, Viral/blood , Asymptomatic Infections , CD4 Lymphocyte Count , Child , Female , France , HIV Infections/complications , HIV Infections/virology , Humans , Male , Middle Aged , Retrospective Studies , Travel , Vaccination/adverse effects , Viral Load , Yellow Fever/virology , Yellow Fever Vaccine/administration & dosage , Yellow Fever Vaccine/immunology
12.
Emerg Infect Dis ; 16(3): 546-8, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20202443

ABSTRACT

We describe clinical and parasitologic features of in vivo and in vitro Plasmodium falciparum resistance to quinine in a nonimmune traveler who returned to France from Senegal in 2007 with severe imported malaria. Clinical quinine failure was associated with a 50% inhibitory concentration of 829 nmol/L. Increased vigilance is required during treatment follow-up.


Subject(s)
Antimalarials/pharmacology , Drug Resistance , Plasmodium falciparum/drug effects , Quinine/pharmacology , Travel , Adolescent , Antimalarials/administration & dosage , France , Humans , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Male , Parasitic Sensitivity Tests , Quinine/administration & dosage , Senegal
13.
J Clin Virol ; 47(1): 85-8, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20004145

ABSTRACT

BACKGROUND: In 2005-2006, a major epidemic of CHIKV infection occurred in the Islands of the south-western Indian Ocean, and longstanding manifestations seemed to be more frequent than described before. OBJECTIVES: To describe the frequency and related factors of late clinical manifestations of CHIKV infection among imported cases living in Aquitaine area, France. STUDY DESIGN: All patients recruited through the travel clinic and tropical medicine unit of the University Hospital Centre of Bordeaux with possible CHIKV infection were prospectively recorded, and confirmed cases of CHIKV infection were interviewed 2 years after infection. Factors associated with the persistence of symptoms were determined by multivariate logistic regression. RESULTS: Among the 29 cases followed, 17 still suffered from arthralgia 2 years after infection, and most of them had never recovered from the initial phase of the condition. The risk of persistent arthralgia tended to be higher among subjects with low educational level, subjects infected in the Reunion Island, and when initial phase lasted 30 days or more and was characterised by a severe pain. CONCLUSIONS: Consistent with previous studies, our findings showed worsened late manifestations among patients returning from Indian Ocean area. Persistence of symptoms tended to be linked with clinical burden during the acute phase, which can be informative for early recognition and management of patients at risk for developing persistent rheumatic symptoms. Cryoglobulins failed to be identified in seronegative patients with invalidating dengue-like syndrome.


Subject(s)
Alphavirus Infections/epidemiology , Arthralgia/epidemiology , Chikungunya virus/isolation & purification , Disease Outbreaks/statistics & numerical data , Travel/statistics & numerical data , Adult , Aged , Aged, 80 and over , Alphavirus Infections/virology , Analysis of Variance , Arthralgia/virology , Cryoglobulins/analysis , Female , France/ethnology , Humans , Indian Ocean Islands/epidemiology , Male , Middle Aged , Prospective Studies , Risk Factors
14.
BMC Infect Dis ; 9: 200, 2009 Dec 10.
Article in English | MEDLINE | ID: mdl-20003320

ABSTRACT

BACKGROUND: Chikungunya fever is an emerging arboviral disease characterized by an algo-eruptive syndrome, inflammatory polyarthralgias, or tenosynovitis that can last for months to years. Up to now, the pathophysiology of the chronic stage is poorly understood. CASE PRESENTATION: We report the first case of CHIKV infection with chronic associated rheumatism in a patient who developed progressive erosive arthritis with expression of inflammatory mediators and persistence of specific IgM antibodies over 24 months following infection. CONCLUSIONS: Understanding the specific features of chikungunya virus as well as how the virus interacts with its host are essential for the prevention, treatment or cure of chikungunya disease.


Subject(s)
Alphavirus Infections/complications , Antibodies, Viral/blood , Arthritis, Infectious/etiology , Chikungunya virus/immunology , Immunoglobulin M/blood , Alphavirus Infections/blood , Alphavirus Infections/immunology , Arthritis, Infectious/blood , Arthritis, Infectious/immunology , Humans , Male , Middle Aged
15.
J Travel Med ; 16(4): 286-8, 2009.
Article in English | MEDLINE | ID: mdl-19674271

ABSTRACT

Chikungunya virus (CHIKV) infection has been reported in West Africa since 1966, with the last outbreaks from Senegal in 1996 and 1997. We report a cluster of CHIKV infection among travelers returning from Senegal in 2006. Eight imported cases of dengue-like syndrome with fever, joint pain, and skin manifestations were investigated.


Subject(s)
Alphavirus Infections/diagnosis , Alphavirus Infections/epidemiology , Chikungunya virus , Travel , Adult , Chikungunya virus/immunology , Chikungunya virus/isolation & purification , Disease Outbreaks , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Middle Aged , Senegal/epidemiology
16.
Travel Med Infect Dis ; 7(1): 52-4, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19174303

ABSTRACT

A major Chikungunya virus (CHIKV) epidemic affected the South-Western Indian Ocean islands in 2005. This major outbreak raised concerns about the possibility of the emergence of CHIKV infections in Europe as an autochthonous CHIKV outbreak occurred in the Ravenna region of Italy during the summer of 2007 and was linked to a viraemic index case originating in Kerala, India. This report highlights the need for surveillance in countries where such emerging infections could be introduced by returning travellers.


Subject(s)
Alphavirus Infections/epidemiology , Arthritis, Infectious/virology , Chikungunya virus/isolation & purification , Communicable Diseases, Emerging/epidemiology , Disease Outbreaks/statistics & numerical data , Travel , Alphavirus Infections/diagnosis , Alphavirus Infections/prevention & control , Alphavirus Infections/transmission , Diagnosis, Differential , Disease Outbreaks/prevention & control , Humans , Madagascar/epidemiology , Male , Young Adult
17.
Travel Med Infect Dis ; 6(5): 301-4, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18760253

ABSTRACT

BACKGROUND: Outbreaks of eosinophilic meningitis are reported rarely, even in regions of endemic infestation with the roundworm Angiostrongylus cantonensis, such as the Pacific Basin. We report a cluster of eosinophilic meningitis presumably attributable to A. cantonensis among French policemen returning from French Polynesia. METHODS: A retrospective cohort study among French policemen who had stayed in Tahiti was conducted using a clinical definition of eosinophilic meningitis that included severe headache within 30 days after return and eosinophilia, and who consumed locally exotic ethnic dishes with uncooked freshwater prawns. RESULTS: Five persons met the case definition for eosinophilic meningitis. Corticosteroid therapy associated with antihelminthic regimen led to improvement of symptoms in one patient. Other patients were treated with albendazole alone. All patients recovered. CONCLUSION: Among travellers at risk, the presence of severe headache and eosinophilia combined with a consistent exposure history to exotic food should alert to the possibility of A. cantonensis infestation. Travellers should be aware of the risk of infection associated with eating exotic ethnic dishes.


Subject(s)
Eosinophilia/diagnosis , Meningitis/diagnosis , Strongylida Infections/diagnosis , Travel , Adult , Albendazole/administration & dosage , Albendazole/therapeutic use , Angiostrongylus cantonensis/immunology , Animals , Anthelmintics/therapeutic use , Cohort Studies , Eosinophilia/drug therapy , Eosinophilia/epidemiology , Food Contamination , Headache/etiology , Humans , Ivermectin/administration & dosage , Ivermectin/therapeutic use , Meningitis/complications , Meningitis/drug therapy , Meningitis/epidemiology , Police , Polynesia , Retrospective Studies , Seafood , Strongylida Infections/drug therapy , Strongylida Infections/epidemiology
18.
Travel Med Infect Dis ; 6(3): 152-4, 2008 May.
Article in English | MEDLINE | ID: mdl-18486073

ABSTRACT

Chikungunya virus infection is a vector-borne self-limiting disease. Recent outbreaks in the Indian Ocean islands have drawn attention to the condition. Nevertheless, only a few reports of co-infection with other communicable agents have been reported. The case described now is of a traveller returning from India with concomitant documented chikungunya virus infection associated with systemic amoebiasis. This report highlights the multifaceted pathology that can be encountered with tropical infections.


Subject(s)
Alphavirus Infections/diagnosis , Chikungunya virus , Communicable Diseases, Emerging/diagnosis , Entamoeba histolytica , Entamoebiasis/diagnosis , Travel , Aged , Aged, 80 and over , Alphavirus Infections/complications , Animals , Communicable Diseases, Emerging/complications , Diagnosis, Differential , Entamoebiasis/complications , France , Humans , India , Male
19.
Travel Med Infect Dis ; 6(3): 155-7, 2008 May.
Article in English | MEDLINE | ID: mdl-18486074

ABSTRACT

Schistosomiasis, an infection with the three anthropophilic species of Schistosoma, is endemic throughout wide areas of the tropics and subtropics with an estimated rate of over 200 million people infected worldwide. Whereas symptoms and signs of vesical and gastrointestinal forms of the infection are recognized readily, cutaneous manifestations are still a challenging diagnosis particularly in Western countries. A case is described of a 34-year-old Caucasian pregnant woman who presented to our department and was diagnosed with a cutaneous schistosomiasis involvement of the perianal region. Shistosoma haematobium was shown to be present in the lesion by histopathology and was considered to be the causative organism of the disease. Treatment with a course of oral praziquantel in a dose of 40mg/kg allowed resolution of the symptoms.


Subject(s)
Granuloma/diagnosis , Pregnancy Complications, Infectious/diagnosis , Schistosomiasis/diagnosis , Skin Diseases, Parasitic/diagnosis , Travel , Administration, Oral , Adult , Anal Canal , Anthelmintics/therapeutic use , Diagnosis, Differential , Female , France , Granuloma/drug therapy , Granuloma/pathology , Humans , Mauritania , Praziquantel/therapeutic use , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/pathology , Schistosomiasis/drug therapy , Schistosomiasis/pathology , Skin Diseases, Parasitic/pathology
20.
Malar J ; 7: 70, 2008 Apr 28.
Article in English | MEDLINE | ID: mdl-18442362

ABSTRACT

BACKGROUND: A simple real-time PCR assay using one set of primer and probe for rapid, sensitive and quantitative detection of Plasmodium species, with simultaneous differentiation of Plasmodium falciparum from the three other Plasmodium species (Plasmodium vivax, Plasmodium ovale and Plasmodium malariae) in febrile returning travellers and migrants was developed and evaluated. METHODS: Consensus primers were used to amplify a species-specific region of the multicopy 18S rRNA gene, and fluorescence resonance energy transfer hybridization probes were used for detection in a LightCycler platform (Roche). The anchor probe sequence was designed to be perfect matches to the 18S rRNA gene of the fourth Plasmodium species, while the acceptor probe sequence was designed for P. falciparum over a region containing one mismatched, which allowed differentiation of the three other Plasmodium species. The performance characteristics of the real-time PCR assay were compared with those of conventional PCR and microscopy-based diagnosis from 119 individuals with a suspected clinical diagnostic of imported malaria. RESULTS: Blood samples with parasite densities less than 0.01% were all detected, and analytical sensitivity was 0.5 parasite per PCR reaction. The melt curve means Tms (standard deviation) in clinical isolates were 60.5 degrees C (0.6 degrees C) for P. falciparum infection and 64.6 degrees C (1.8 degrees C) for non-P. falciparum species. These Tms values of the P. falciparum or non-P. falciparum species did not vary with the geographic origin of the parasite. The real-time PCR results correlated with conventional PCR using both genus-specific (Kappa coefficient: 0.95, 95% confidence interval: 0.9 - 1) or P. falciparum-specific (0.91, 0.8 - 1) primers, or with the microscopy results (0.70, 0.6 - 0.8). The real-time assay was 100% sensitive and specific for differentiation of P. falciparum to non-P. falciparum species, compared with conventional PCR or microscopy. The real-time PCR assay can also detect individuals with mixed infections (P. falciparum and non-P. falciparum sp.) in the same sample. CONCLUSION: This real-time PCR assay with melting curve analysis is rapid, and specific for the detection and differentiation of P. falciparum to other Plasmodium species. The suitability for routine use of this assay in clinical diagnostic laboratories is discussed.


Subject(s)
DNA, Protozoan/analysis , Malaria/diagnosis , Plasmodium/isolation & purification , Polymerase Chain Reaction/methods , RNA, Ribosomal, 18S/analysis , Animals , Computer Systems , DNA Primers , DNA, Protozoan/blood , DNA, Protozoan/isolation & purification , Fluorescence Resonance Energy Transfer , Humans , Malaria/parasitology , Plasmodium/classification , Plasmodium/genetics , RNA, Ribosomal, 18S/genetics , Sensitivity and Specificity , Transients and Migrants
SELECTION OF CITATIONS
SEARCH DETAIL
...